CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 645.5	$ 1,068.2
Short-term investments	0.0	100.0
Accounts receivable, net	472.7	416.9
Inventories	800.1	710.1
Assets held for sale	1.4	4.4
Other current assets	193.5	172.2
Total current assets	2,113.2	2,471.8
Property, plant and equipment, net	487.0	406.1
Goodwill	457.6	339.5
Intangible assets, net	270.9	211.8
Operating lease assets	51.2	59.9
Deferred tax assets	76.8	90.1
Other long-term assets	155.1	70.8
Total assets	3,611.8	3,650.0
Current liabilities:
Current portion of long-term debt and finance lease obligations	18.7	112.4
Accounts payable	178.4	147.4
Customer advances	218.0	197.5
Other current liabilities	499.2	481.2
Total current liabilities	914.3	938.5
Long-term debt	1,200.5	1,221.8
Long-term deferred revenue	56.2	50.2
Deferred tax liabilities	62.3	46.0
Operating lease liabilities	34.8	41.8
Accrued pension	45.7	104.7
Other long-term liabilities	166.2	162.2
Commitments And Contingencies
Redeemable noncontrolling interests	6.1	0.2
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2022 and 2021	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 175,389,586 and 174,905,035 shares issued and 147,023,144 and 150,753,687 outstanding at December 31, 2022 and 2021, respectively	1.7	1.7
Treasury stock at cost, 28,366,442 and 24,151,348 shares at December 31, 2022 and 2021, respectively	(1,085.0)	(820.3)
Additional paid-in capital	256.3	237.8
Retained earnings	1,926.0	1,659.5
Accumulated other comprehensive income (loss), net of tax	14.8	(8.2)
Total shareholders' equity attributable to Bruker Corporation	1,113.8	1,070.5
Noncontrolling interests in consolidated subsidiaries	11.9	14.1
Total shareholders' equity	1,125.7	1,084.6
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 3,611.8	$ 3,650.0